FDA releases update on chicken broth recall
The Food and Drug Administration (FDA) has released an update on a recall for chicken broth sold at Georgia Walmarts.
US FDA drops web pages on improving clinical trial diversity
The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and ...
Abeona Therapeutics: Despite Some Competitive Pressure, This Looks Undervalued
Abeona Therapeutics Inc.'s promising gene therapy for RDEB, potential FDA approval, undervalued stock, and key risks. Click ...
Exerts debunk "autism detox" misinformation. Here's what to know.
"Autism detox" treatments, which include minerals like zeolite, are rising in popularity for promising to treat or reverse ...
FDA pauses updates on food-borne outbreak probes as health agencies regroup on communications
The Trump administration's "short pause" on communications, expected to end on Feb. 1, has affected FDA updates on food ...
Dip Recall Update as FDA Sets Risk Class
The spinach artichoke dip mix was recalled due to it having been underprocessed, the Food and Drug Administration said.
Spice distributed in several states, including N.Y., recalled for possible health risk
Yu Yee, Five Spice Powder, packaged in 1.76-ounce containers, has been recalled due to high levels of lead, according to the FDA. The popular Chinese spice blend is often used for frying, stewing, dry ...
Trump Orders CDC, FDA, and Other Health Agencies to Go Dark
The Centers for Disease Control and Prevention is going dark, along with other federal agencies within the umbrella of the ...
The Powers Trump’s Nominees Will Have Over Abortion
Here are some of the actions Trump’s nominees could take on abortion, if confirmed, from HHS to the Justice Department.
STAT3d
A next-generation form of chemotherapy wins FDA approval
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Atara extends losses after FDA clinical hold
Atara Biotherapeutics (ATRA) stock slips as company faces an FDA clinical hold after rejection of lead candidate Ebvallo.
Food companies want to confuse consumers. The FDA must push back.
Food companies criticize the science supporting front-of-package labeling, delay public consultation periods, push for their ...